Clover Health is trading 4.12% down at $4.30 on September 28, 2026, as broad markets weaken after President Trump rejected Iran’s proposal.
- No clear company-specific catalyst surfaced in the available coverage.
- Oil prices rose, reigniting inflation and higher-rate concerns; the S&P 500 and Nasdaq were also down more than 0.5% in the provided market context, consistent with pressure across equities.